← Back to Search
A Critical Evaluation Of Comparative Regulatory Strategies For Monitoring Pharmaceuticals In Recycled Wastewater.
Olga Miarov, A. Tal, D. Avisar
Published 2019 · Medicine, Business
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Pharmaceuticals are a subset of micropollutants, present in the environment in trace concentrations. Because of their persistent nature, these chemicals are of particular concern. Little is known about how mixtures of pharmaceutical residues, found in WWTP effluents, affect the environment or public health. Yet, numerous studies show negative outcomes for both aquatic and terrestrial organisms, suggesting that they are given both to bioaccumulation and uptake in plants. Israel leads the world in effluent reuse (86%), almost exclusively utilized for purposes of agricultural irrigation. Pharmaceuticals, however, are not included in Israel's water regulatory oversight or management, essentially creating an epidemiological experiment among its citizens and environment. Globally, these compounds also are not commonly subject to monitoring or regulation. This study reviews and analyzes water policies and regulation worldwide that address the presence of pharmaceuticals in water resources, with a particular focus on Australia, Singapore, Switzerland, and the USA. Furthermore, the study investigates the reasons why these chemicals are not yet regulated in Israel. Based on a comprehensive evaluation of the data and analysis of the regulatory rationale in other countries, a list of recommended pharmaceutical standards that should be measured and monitored in Israel's wastewater treatment system is proposed. The suggested prioritization criteria should be at the heart of a new regulatory agenda for controlling pharmaceutical contamination in wastewater.
This paper references
Policy analysis is what information systems are not
A. Wildavsky (1978)
Presence of therapeutic drugs in the environment
E. Zuccato (2000)
Strategic Survey of Therapeutic Drugs in the Rivers Po and Lambro in Northern Italy
D. Calamari (2003)
Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris.
D. Pascoe (2003)
Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
M. Carballa (2004)
Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration.
M. Clara (2004)
Diclofenac residues as the cause of vulture population decline in Pakistan
J. Oaks (2004)
Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environment.
E. O'brien (2004)
Human Biomonitoring of Environmental Chemicals
K. Sexton (2004)
Quantification of sewer exfiltration using the anti-epileptic drug carbamazepine as marker species for wastewater.
R. Fenz (2005)
Mammalian sex hormones in plants.
A. Janeczko (2005)
Neuropharmaceuticals in the environment: mianserin-induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays.
K. van der Ven (2006)
Development of an International Priority List of Pharmaceuticals relevant for the Water Cycle
P. Voogt (2007)
Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary Prioritization
J. Besse (2008)
Norfluoxetine Induces Spawning and Parturition in Estuarine and Freshwater Bivalves
P. P. Fong (2008)
The processes affecting oxytetracycline contamination of groundwater in a phreatic aquifer underlying industrial fish ponds in Israel
D. Avisar (2009)
Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
C. Miège (2009)
Detection of amoxicillin-diketopiperazine-2′, 5′ in wastewater samples
Assaf Lamm (2009)
Sulfamethoxazole contamination of a deep phreatic aquifer.
D. Avisar (2009)
Effects of fluoxetine on the reproduction of two prosobranch mollusks: Potamopyrgus antipodarum and Valvata piscinalis.
M. Gust (2009)
Economics of Environment
S. Muthukrishnan (2010)
Investigation of an amoxicillin oxidative degradation product formed under controlled environmental conditions
I. Gozlan (2010)
Quantitative evaluation of tracers for quantification of wastewater contamination of potable water sources.
G. Gasser (2010)
Treatment of Micropollutants in Water and Wastewater
J. Virkutyte (2010)
Sorption of Sulfonamides and Tetracyclines to Montmorillonite Clay
D. Avisar (2010)
Further evidence on the high prevalence of male factor infertility diagnosis in Israel.
T. Sella (2011)
Estrogen action and prostate cancer
Jason L Nelles (2011)
Development Method for Extracting and Analyzing Antibiotic and Hormone Residues from Treated Wastewater Sludge and Composted Biosolids
Michelle Shafrir (2012)
Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
V. Roos (2012)
Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?
A. Boxall (2012)
Amoxicillin-degradation products formed under controlled environmental conditions: identification and determination in the aquatic environment.
I. Gozlan (2013)
The Read-Across Hypothesis and Environmental Risk Assessment of Pharmaceuticals
M. Rand-Weaver (2013)
Treating wastewater from a pharmaceutical formulation facility by biological process and ozone.
Y. Lester (2013)
The effects of synthetic estrogen exposure on premating and postmating episodes of selection in sex-role-reversed Gulf pipefish
E. Rose (2013)
Global Synthesis and Critical Evaluation of Pharmaceutical Data Sets Collected from River Systems
S. Hughes (2013)
POCIS passive samplers as a monitoring tool for pharmaceutical residues and their transformation products in marine environment
M. M. Martínez Bueno (2014)
Long-Term Secular Trends in the Age at Menarche in Israel: A Systematic Literature Review and Pooled Analysis
Shira Flash-Luzzatti (2014)
Insights into the uptake processes of wastewater-borne pharmaceuticals by vegetables.
Myah Goldstein (2014)
Irrigation of root vegetables with treated wastewater: evaluating uptake of pharmaceuticals and the associated human health risks.
Tomer Malchi (2014)
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.
T. V. Van Boeckel (2014)
Biodegradability of pharmaceutical compounds in agricultural soils irrigated with treated wastewater.
Amnon Grossberger (2014)
Antimicrobial residues in foods of animal origin in Africa: public health risks.
S. Mensah (2014)
Naproxen-Enriched Artificial Sediment Induces Oxidative Stress and Genotoxicity in Hyalella azteca
García-Medina Alba Lucero (2015)
Major national human biomonitoring programs in chemical exposure assessment
Judy Choi (2015)
A hybrid process of biofiltration of secondary effluent followed by ozonation and short soil aquifer treatment for water reuse.
I. Zucker (2015)
Transformation Pathways of the Recalcitrant Pharmaceutical Compound Carbamazepine by the White-Rot Fungus Pleurotus ostreatus: Effects of Growth Conditions.
Naama Golan-Rozen (2015)
Fourth Unregulated Contaminant Monitoring Rule
Effects of the non-steroidal anti-inflammatory drug(NSAID) naproxen on gene expression of antioxidant enzymes in zebrafish (Danio rerio).
V. Stancová (2015)
Environmental exposure to pharmaceuticals: A new technique for trace analysis of carbamazepine and its metabolites in human urine.
G. Fedorova (2016)
Diclofenac and its transformation products: Environmental occurrence and toxicity - A review.
Linson Lonappan (2016)
Fate and effects of the residues of anticancer drugs in the environment
E. Heath (2016)
Fluoxetine Exhibits Pharmacological Effects and Trait-Based Sensitivity in a Marine Worm.
Cameron M. Hird (2016)
Rethinking the sustainability of Israel's irrigation practices in the Drylands.
A. Tal (2016)
Pharmaceuticals in the environment--Global occurrences and perspectives.
Tim aus der Beek (2016)
Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine.
L. Kristofco (2016)
Effects of trophic exposure to diclofenac and dexamethasone on hematological parameters and immune response in freshwater fish.
J. L. C. Ribas (2016)
Risk-based prioritization of pharmaceuticals in the natural environment in Iraq
O. Al-Khazrajy (2016)
Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems.
S. Daouk (2016)
Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
S. Moore (2016)
Pharmaceuticals May Disrupt Natural Chemical Information Flows and Species Interactions in Aquatic Systems: Ideas and Perspectives on a Hidden Global Change.
E. van Donk (2016)
Human Exposure to Wastewater-Derived Pharmaceuticals in Fresh Produce: A Randomized Controlled Trial Focusing on Carbamazepine.
O. Paltiel (2016)
Household medical waste disposal policy in Israel
Zohar Barnett-Itzhaki (2016)
The effects of antidepressants appear to be rapid and at environmentally relevant concentrations.
A. Ford (2016)
Fate of carbamazepine, its metabolites, and lamotrigine in soils irrigated with reclaimed wastewater: Sorption, leaching and plant uptake.
A. Paz (2016)
Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment.
Jiahua Guo (2016)
Diclofenac affects kidney histology in the three-spined stickleback (Gasterosteus aculeatus) at low μg/L concentrations.
J. Näslund (2017)
SSRIs antidepressants in marine mussels from Atlantic coastal areas and human risk assessment.
L. Silva (2017)
Environmental impact of estrogens on human, animal and plant life: A critical review.
Muhammad Adeel (2017)
Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
B. Aubakirova (2017)
Effect of antidepressants on circadian rhythms in fish: Insights and implications regarding the design of behavioural toxicity tests.
S. Melvin (2017)
Occurrence and risk assessment of antidepressants in Huangpu River of Shanghai, China
M. Wu (2017)
Global scanning of antihistamines in the environment: Analysis of occurrence and hazards in aquatic systems.
L. Kristofco (2017)
Human biomonitoring in Israel: Recent results and lessons learned.
T. Berman (2017)
Effects of environmentally relevant concentrations of the anti-inflammatory drug diclofenac in freshwater fish Rhamdia quelen.
I. C. Guiloski (2017)
The Role of Soil Aquifer Treatment (SAT) for Effective Removal of Organic Matter, Trace Organic Compounds and Microorganisms from Secondary Effluents Pre-Treated by Ozone
A. Lakretz (2017)
Pay special attention to the transformation products of PPCPs in environment
Lina Yin (2017)
Addressing Desalination’s Carbon Footprint: The Israeli Experience
A. Tal (2018)
Acute exposure to an environmentally relevant concentration of diclofenac elicits oxidative stress in the culturally important galaxiid fish Galaxias maculatus.
N. McRae (2018)
Customer Service Advisor
Sophie Hawes (2018)
Composted biosolids and treated wastewater as sources of pharmaceuticals and personal care products for plant uptake: A case study with carbamazepine.
Evyatar Ben Mordechay (2018)
This paper is referenced by
Analysis of WWTPs technologies based on the removal efficiency of Pharmaceutical Activated Compounds for water reuse purposes. A Fuzzy Multi-Criteria Decision Making approach
C. Fernández-López (2021)
Occurrence and removal of pharmaceuticals in wastewater treatment plants
Omar Fawzi Suleiman Khasawneh (2021)
Treatment of pharmaceutical and personal care products in wastewater
Purvi Mathur (2021)
Emerging contaminants in the water bodies of the Middle East and North Africa (MENA): A critical review.
Mariam Ouda (2021)
Application of Pleurotus ostreatus to efficient removal of selected antidepressants and immunosuppressant.
Bartosz Kózka (2020)
Risk Evaluation and Legal Framework of the Nonsteroidal Anti-inflammatory Drugs Around the World
Jesús Daniel Cardoso-Vera (2020)
Advanced Wastewater Treatment to Eliminate Organic Micropollutants in Wastewater Treatment Plants in Combination with Energy-Efficient Electrolysis at WWTP Mainz
Oliver Gretzschel (2020)
Sources of Pharmaceuticals in Water
R. Parra-Saldívar (2020)
Development of poly(vinyl alcohol)-based membranes by the response surface methodology for environmental applications
J. Merck (2020)
Water efficiency and safe re-use of different grades of water - Topical issues for the pharmaceutical industry
E. Strade (2020)
Toxic effects of NSAIDs in non-target species: A review from the perspective of the aquatic environment.
K. Świacka (2020)
Non-Steroidal Anti-Inflammatory Drugs in Water: Emerging Contaminants and Ecological Impact
A. Kostianoy (2020)